Pascal Deschatelets
2020
In 2020, Pascal Deschatelets earned a total compensation of $2.9M as Chief Scientific Officer at Apellis Pharmaceuticals, a 60% increase compared to previous year.
Compensation breakdown
| Bonus | $239,062 |
|---|---|
| Option Awards | $1,828,125 |
| Salary | $423,500 |
| Stock Awards | $415,594 |
| Other | $11,801 |
| Total | $2,918,082 |
Deschatelets received $1.8M in option awards, accounting for 63% of the total pay in 2020.
Deschatelets also received $239.1K in bonus, $423.5K in salary, $415.6K in stock awards and $11.8K in other compensation.
Rankings
In 2020, Pascal Deschatelets' compensation ranked 3,968th out of 13,090 executives tracked by ExecPay. In other words, Deschatelets earned more than 69.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,968 out of 13,090 | 70th |
Division Manufacturing | 1,590 out of 5,624 | 72nd |
Major group Chemicals And Allied Products | 601 out of 2,257 | 73rd |
Industry group Drugs | 519 out of 1,957 | 74th |
Industry Pharmaceutical Preparations | 393 out of 1,462 | 73rd |
Source: SEC filing on April 22, 2021.
Deschatelets' colleagues
We found four more compensation records of executives who worked with Pascal Deschatelets at Apellis Pharmaceuticals in 2020.
News
Apellis Pharmaceuticals CEO Cedric Francois' 2021 pay slips 2% to $9.1M
April 20, 2022
Apellis Pharmaceuticals CEO Cedric Francois' 2020 pay jumps 117% to $9.3M
April 22, 2021
Apellis Pharmaceuticals CEO Cedric Francois' 2019 pay rises 5% to $4.3M
April 22, 2020
Apellis Pharmaceuticals CEO Cedric Francois' 2018 pay jumps 145% to $4.1M
April 30, 2019